{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:21:59Z","timestamp":1790086919782,"version":"4.0.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>Premortem interventions (PMIs) for organ donation play a vital role in preserving opportunities for deceased donation or increasing the chances of successful transplantation of donor organs. Although ethical considerations relating to use of particular PMIs have been well explored, the ethical and legal aspects of decision-making about the use of PMIs have received comparatively little attention. In many countries, there is significant uncertainty regarding whether PMIs are lawful or, if they are, who can authorize them. Furthermore, emphasis on consideration of therapeutic goals in substitute decision-making frameworks may discourage consideration of donation goals. In this article, we examine the fundamental questions of who should have the authority to make decisions about the use of PMIs on behalf of a potential donor and how such decisions should be made. We draw on international examples of legal reform that have sought to clarify the legal position in relation to administering PMIs and identify potential elements of an effective regulatory model for PMIs. In doing so, we argue that reforms are needed in many countries to provide legal certainty for clinicians who are responsible for supporting decision-making about PMIs and to ensure that the goals and preferences of potential donors are accorded due consideration in the decision-making process.<\/jats:p>","DOI":"10.1097\/tp.0000000000004591","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T04:01:51Z","timestamp":1681790511000},"page":"1655-1663","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Decision-making About Premortem Interventions for Donation: Navigating Legal and Ethical Complexities"],"prefix":"10.1097","volume":"107","author":[{"given":"Shih-Ning","family":"Then","sequence":"first","affiliation":[{"name":"Australian Centre for Health Law Research, Faculty of Business and Law, Queensland University of Technology, Brisbane City, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique E.","family":"Martin","sequence":"additional","affiliation":[{"name":"School of Medicine, Deakin University, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McGee","sequence":"additional","affiliation":[{"name":"Australian Centre for Health Law Research, Faculty of Business and Law, Queensland University of Technology, Brisbane City, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Gardiner","sequence":"additional","affiliation":[{"name":"Adult Intensive Care, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"El Moslemani","sequence":"additional","affiliation":[{"name":"Minter Ellison Lawyers, Brisbane, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"100635","DOI":"10.1016\/j.trre.2021.100635","article-title":"Ethical considerations in the use of pre-mortem interventions to support deceased organ donation: a scoping review.","volume":"35","author":"Weiss","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/ajt.15253","article-title":"Summary of Spanish recommendations on intensive care to facilitate organ donation.","volume":"19","author":"Mart\u00edn-Delgado","year":"2019","journal-title":"Am J Transplant"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1097\/TP.0000000000003793","article-title":"Antemortem heparin in organ donation after circulatory death determination: a systematic review of the literature.","volume":"105","author":"Honarmand","year":"2021","journal-title":"Transplantation"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/lt.25685","article-title":"Transplant outcomes of donation after circulatory death livers recovered with versus without premortem heparin administration.","volume":"26","author":"Narvaez","year":"2020","journal-title":"Liver Transpl"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s12630-022-02288-z","article-title":"Best foot forward: now is the time for Canadian ethical guidance on prospective interventional trials of antemortem interventions in organ donation.","volume":"69","author":"Murphy","year":"2022","journal-title":"Can J Anaesth"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1477750916657658","article-title":"Pre-mortem interventions for donation after circulatory death and overall benefit: a qualitative study.","volume":"11","author":"Gathani","year":"2016","journal-title":"Clin Ethics"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1017\/jme.2021.63","article-title":"Controlled donation after circulatory determination of death: a scoping review of ethical issues, key concepts, and arguments.","volume":"49","author":"Murphy","year":"2021","journal-title":"J Law Med Ethics"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/ajt.12660","article-title":"Family perspectives on deceased organ donation: thematic synthesis of qualitative studies.","volume":"14","author":"Ralph","year":"2014","journal-title":"Am J Transplant"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/ajt.14464","article-title":"Harms of unsuccessful donation after circulatory death: an exploratory study.","volume":"18","author":"Taylor","year":"2018","journal-title":"Am J Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2307\/3527865","article-title":"Delimiting the donor: the dead donor rule.","volume":"29","author":"Robertson","year":"1999","journal-title":"Hastings Cent Rep"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bjae.2021.03.003","article-title":"Two fundamental ethical and legal rules for deceased organ donation.","volume":"21","author":"Gardiner","year":"2021","journal-title":"BJA Educ"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jcrc.2020.06.016","article-title":"Conflicts of interest in the context of end of life care for potential organ donors in Australia.","volume":"59","author":"van Haren","year":"2020","journal-title":"J Crit Care"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1503\/cmaj.060895","article-title":"Donation after cardiocirculatory death in Canada.","volume":"175","author":"Shemie","year":"2006","journal-title":"CMAJ"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00134-019-05533-0","article-title":"Organ donation after circulatory death: current status and future potential.","volume":"45","author":"Smith","year":"2019","journal-title":"Intensive Care Med"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/TP.0b013e31824836fa","article-title":"Whose consent matters? Controlled donation after cardiac death and premortem organ-preserving measures.","volume":"93","author":"Bastami","year":"2012","journal-title":"Transplantation"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/TP.0000000000001696","article-title":"End-of-life conversations with families of potential donors: leading practices in offering the opportunity for organ donation.","volume":"101","author":"Shemie","year":"2017","journal-title":"Transplantation"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15265161.2015.1047999","article-title":"Addressing consent issues in donation after circulatory determination of death.","volume":"15","author":"Overby","year":"2015","journal-title":"Am J Bioeth"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12910-021-00734-z","article-title":"A scoping review of the perceptions of death in the context of organ donation and transplantation.","volume":"22","author":"Skowronski","year":"2021","journal-title":"BMC Med Ethics"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/virtualmentor.2012.14.3.coet1-1203","article-title":"AMA Code of Medical Ethics\u2019 opinions on organ transplantation.","volume":"14","year":"2012","journal-title":"AMA J Ethics"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/BF03016313","article-title":"Pre-mortem transplantation optimizing interventions: the legal status of consent.","volume":"55","author":"Downie","year":"2008","journal-title":"Can J Anaesth"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11019-014-9548-y","article-title":"What does \u2018\u2018presumed consent\u2019\u2019 might presume? Preservation measures and uncontrolled donation after circulatory determination of death.","volume":"17","author":"de Lora","year":"2014","journal-title":"Med Health Care Philos"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12630-021-01928-0","article-title":"Family veto in organ donation: the experiences of organ and tissue donation coordinators in Ontario.","volume":"68","author":"Anthony","year":"2021","journal-title":"Can J Anaesth"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1097\/TP.0000000000002622","article-title":"The role of the family in deceased organ procurement: a guide for clinicians and policymakers.","volume":"103","author":"Delgado","year":"2019","journal-title":"Transplantation"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/medethics-2020-106572","article-title":"Transitions in decision-making authority at the end of life: a problem of law, ethics and practice in deceased donation.","volume":"48","author":"Then","year":"2022","journal-title":"J Med Ethics"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/medethics-2015-103098","article-title":"Premortem interventions in dying children to optimise organ donation: an ethical analysis.","volume":"42","author":"Brierley","year":"2016","journal-title":"J Med Ethics"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:07:49Z","timestamp":1749060469000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004591","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,18]]}}}